Neurizon TherapeuticsFRA:ECQ0 +3.08% Days Inventory is 0.00 as of Dec. 2025. The stock has 2 warning signs investors should review. Among 635 Biotechnology companies, Neurizon Therapeutics ranks worse than 157480.16% on this metric.
The historical rank and industry rank for Neurizon Therapeutics's Days Inventory or its related term are showing as below:
During the past 13 years, Neurizon Therapeutics's highest Days Inventory was 1513.53. The lowest was 434.24. And the median was 660.00.
FRA:ECQ0's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.23 * Ranked among companies with meaningful Days Inventory only.
Neurizon Therapeutics's Days Inventory
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Neurizon Therapeutics (FRA:ECQ0) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Neurizon Therapeutics's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Neurizon Therapeutics's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Neurizon Therapeutics Days Inventory Related Terms
Neurizon Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for Neurizon Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ECQ0 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Neurizon Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurizon Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Neurizon Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurizon Therapeutics (FRA:ECQ0) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Neurizon Therapeutics and its competitors. Over the past decade, Neurizon Therapeutics' Days Inventory has ranged from 434.24 to 1,513.53. According to the industry distribution chart, Neurizon Therapeutics ranks #999999 out of 635 companies in the Biotechnology industry.
Is Neurizon Therapeutics' Days Inventory too high?
Neurizon Therapeutics' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 434.24 to a high of 1,513.53. Based on the distribution chart, Neurizon Therapeutics ranks #999999 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Neurizon Therapeutics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Neurizon Therapeutics ranks #999999 out of 635 companies for Days Inventory. This places Neurizon Therapeutics in the lower half of its industry. The industry median Days Inventory is 183.23. Historically, Neurizon Therapeutics' own Days Inventory has ranged from 434.24 to 1,513.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Neurizon Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurizon Therapeutics's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurizon Therapeutics stock overvalued right now?
Neurizon Therapeutics (FRA:ECQ0) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Neurizon Therapeutics (FRA:ECQ0), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ECQ0 has been successfully added to your 